BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19962254)

  • 1. Breast cancer and steroid metabolizing enzymes: the role of progestogens.
    Pasqualini JR
    Maturitas; 2009 Dec; 65 Suppl 1():S17-21. PubMed ID: 19962254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestins in the menopause in healthy women and breast cancer patients.
    Pasqualini JR
    Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
    Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
    Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
    Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
    Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of progestins on breast tissue enzymes.
    Pasqualini JR
    Maturitas; 2003 Dec; 46 Suppl 1():S45-54. PubMed ID: 14670645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
    Pasqualini JR
    Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
    Smuc T; Rizner TL
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
    Aka JA; Mazumdar M; Lin SX
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective estrogen enzyme modulator (SEEM) in breast cancer.
    Chetrite GS; Pasqualini JR
    J Steroid Biochem Mol Biol; 2001; 76(1-5):95-104. PubMed ID: 11384867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects of progestins in breast cancer.
    Pasqualini JR; Ebert C; Chetrite GS
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():44-52. PubMed ID: 12227886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological effects of progestins in breast cancer.
    Pasqualini JR; Ebert C
    Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():11-9. PubMed ID: 12227897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen sulfotransferases in breast and endometrial cancers.
    Pasqualini JR
    Ann N Y Acad Sci; 2009 Feb; 1155():88-98. PubMed ID: 19250196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
    Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
    Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
    Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
    Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.